Search for: "Ortho-McNeil Pharmaceutical, Inc. "
Results 121 - 140
of 169
Sorted by Relevance
|
Sort by Date
18 Jan 2016, 5:00 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 808 F.3d 281 (6th Cir. 2015) – preemption, but not involving generic drugs − which aptly described pre-approval theories as “never-start selling” claims (id. at 300), describes that other decision. [read post]
7 Feb 2011, 6:53 pm
In Ortho-McNeil Pharmaceutical, Inc. v. [read post]
22 Apr 2016, 12:51 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 808 F. 3d 281 (6th Cir. 2015); In re Celexa & Lexapro Marketing & Sales Practices Litigation, 779 F.3d 34 (1st Cir. 2015).Now there are three, and the latest is the most a fortiori of the lot.The Third Circuit has applied the Mensing/Bartlettimpossibility preemption rationale outside of the FDCA altogether, to preemption of design defect claims involving airplanes. [read post]
24 Sep 2010, 1:15 pm
Ortho-McNeil Pharmaceutical, Inc. v. [read post]
10 Mar 2014, 11:31 am
Ortho-McNeil-Janssen Pharmaceuticals, 2013 WL 2917651, at *28 (Pa. [read post]
3 Mar 2016, 5:19 am
Biomet, Inc., 492 F. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
2 Sep 2010, 10:51 am
Ortho-McNeil Pharmaceutical, Inc. v. [read post]
7 Apr 2010, 4:30 am
Reddy's Laboratories, Ltd. et al (Docket Report) Retin-A Micro (Tretinoin) – US: District Court E D Texas: Promote Innovation files false marking complaint against Ortho-McNeil based on marking of Retin-A Micro product (Patent Docs) Seasonique (Levonorgestrel, Ethinyl estradiol) – US: Teva receives favourable court decision regarding Seasonique (SmartBrief) (The IP Factor) T2007 (Diphenyl barbituric acid) – US: Taro receives patent for new drug T2007 (The IP… [read post]
3 Jun 2010, 5:42 pm
Kappos and Ortho-McNeil Pharmaceutical, Inc. v. [read post]
24 Sep 2015, 5:24 am
Ct. 2567 (2011), and Mutual Pharmaceutical Co. v. [read post]
31 Dec 2014, 5:00 am
Ortho-McNeil-Janssen Pharmaceutical, Inc. v. [read post]
17 Feb 2012, 11:29 am
Ortho-McNeil-Janssen Pharmaceuticals Inc., 2010 WL 3548474 (Pa. [read post]
20 Mar 2015, 9:16 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2012-206987, 2015 WL 775094 (S.C. [read post]
6 Jul 2007, 4:29 am
Hoffman-La Roche, Inc., 618 N. [read post]
24 Dec 2015, 8:20 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 777 S.E.2d 176 (S.C. 2015). [read post]
5 Sep 2013, 12:24 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 808 F. [read post]
19 Dec 2012, 4:08 pm
Reining in patent term extensions for related pharmaceutical products post-Photocure and Ortho-McNeil. [read post]
19 Jul 2007, 1:47 pm
Ortho-McNeil Pharmaceutical, Inc., 461 F. [read post]
